Paeoniflorin as a candidate disease-modifying therapy for diabetic peripheral neuropathy: mechanisms, exposure challenges, and translational priorities.
Liu Y-N, Jia S-Y, Zhou L-S, Tang X-J, Ming Z, Su Y, Lin J-Y
Front Pharmacol. 2026; 17:1751578. PMID: 42051260.Abstract
